Shanghai Henlius Biotech, Inc. (HKG:2696)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
58.65
+2.95 (5.30%)
Sep 30, 2026, 4:08 PM HKT

Shanghai Henlius Biotech Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
867.35827.04820.47546.02-695.26-984.05
Depreciation & Amortization
412.95421.02367.24353.32273.12196.56
Other Amortization
8.398.397.565.914.4832.62
Loss (Gain) From Sale of Assets
-11.52-11.32-0.82-0.720.250.93
Stock-Based Compensation
266.41124.52-2.5912.5248.42
Provision & Write-off of Bad Debts
7.5510.57-5.039.031.640.17
Other Operating Activities
53.6192.51109.11152.88284.19284.61
Change in Accounts Receivable
-553.17-942.48-165.95-283.77-161.41-99.7
Change in Inventory
218.7992.3923.86-22.34-340.64-91.71
Change in Accounts Payable
55.93212.5161.37-108.34312.5620.04
Change in Unearned Revenue
-267.52702.14120.24495.12227.14303.83
Change in Other Net Operating Assets
35.39-231.68-196.15-101.781,063378.68
Operating Cash Flow
1,0941,3061,2421,048981.6290.39
Operating Cash Flow Growth
-37.89%5.13%18.51%6.75%985.96%-

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-210.97-311.37-164.01-473.67-584.97-460.43
Sale of Property, Plant & Equipment
0.170.170.240.026.560.55
Cash Acquisitions
----15--
Sale (Purchase) of Intangibles
-1,220-888.37-673.2-537.77-780.32-670.76
Investment in Securities
-191.733.42-73-120--
Other Investing Activities
---141.98--550.61
Investing Cash Flow
-1,622-1,196-909.97-1,004-1,359-1,681

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-3,8762,6742,5122,8592,096
Total Debt Issued
3,7783,8762,6742,5122,8592,096
Long-Term Debt Repaid
--3,866-3,184-2,237-1,886-1,364
Lease Payments
-99.22-94.75-102.61-90.33-100.8-68.39
Total Debt Repaid
-3,360-3,866-3,184-2,237-1,886-1,364
Net Debt Issued (Repaid)
417.899.13-510.34274.34972.77731.67
Other Financing Activities
-95.09-102.99-133.03-129.91-114.75-83.36
Financing Cash Flow
322.8-93.86-643.37144.43858.02648.3

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-20.77-7.815.186.2737.59-16.77
Net Cash Flow
-225.847.81-296.26194.19518.49-959.33

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
883.2994.251,078574.25396.65-370.04
Free Cash Flow Growth
-42.19%-7.76%87.70%44.77%--
Free Cash Flow Margin
11.88%14.91%18.83%10.64%12.34%-21.99%
Free Cash Flow Per Share
1.611.821.981.060.73-0.69
Levered Free Cash Flow
-400.18-922.42176.66-709.99-1,019-857.51
Unlevered Free Cash Flow
-337.67-858.37253.46-640.9-952.46-804.5
Free Cash Flow After Leases
783.97899.5975.27483.92295.86-438.43

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
95.45102.99133.03129.91114.7583.2
Cash Income Tax Paid
98.055.5628.2620.711.37-
Change in Working Capital
-510.59-167.11-56.64-21.111,101511.13